Affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Pricing
$310/0.1 mg | $1,330/5x0.1 mg | $465/0.1 mL (Biotin) | $465/0.1 mL (FITC) | $465/0.1 mL (AF350) | $465/0.1 mL (AF405) | $465/0.1 mL (AF488) | $465/0.1 mL (AF555) | $465/0.1 mL (AF568)
$310/0.1 mg | $1,330/5x0.1 mg | $570/0.1 mL (Biotin) | $570/0.1 mL (FITC) | $570/0.1 mL (AF350) | $570/0.1 mL (AF405) | $570/0.1 mL (AF488) | $570/0.1 mL (AF555) | $570/0.1 mL (AF568)
Affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Pricing
$310/0.1 mg | $1,330/5x0.1 mg | $465/0.1 mL (Biotin) | $465/0.1 mL (FITC) | $465/0.1 mL (AF350) | $465/0.1 mL (AF405) | $465/0.1 mL (AF488) | $465/0.1 mL (AF555) | $465/0.1 mL (AF568)
$310/0.1 mg | $1,330/5x0.1 mg | $570/0.1 mL (Biotin) | $570/0.1 mL (FITC) | $570/0.1 mL (AF350) | $570/0.1 mL (AF405) | $570/0.1 mL (AF488) | $570/0.1 mL (AF555) | $570/0.1 mL (AF568)
$310/0.1 mg | $1,330/5x0.1 mg | $570/0.1 mL (Biotin) | $570/0.1 mL (FITC) | $570/0.1 mL (AF350) | $570/0.1 mL (AF405) | $570/0.1 mL (AF488) | $570/0.1 mL (AF555) | $570/0.1 mL (AF568)
$310/0.1 mg | $1,330/5x0.1 mg | $570/0.1 mL (Biotin) | $570/0.1 mL (FITC) | $570/0.1 mL (AF350) | $570/0.1 mL (AF405) | $570/0.1 mL (AF488) | $570/0.1 mL (AF555) | $570/0.1 mL (AF568)
$310/0.1 mg | $1,330/5x0.1 mg | $570/0.1 mL (Biotin) | $570/0.1 mL (FITC) | $570/0.1 mL (AF350) | $570/0.1 mL (AF405) | $570/0.1 mL (AF488) | $570/0.1 mL (AF555) | $570/0.1 mL (AF568)
Affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific phosphopeptide. The antibody againstnon-phosphopeptide was removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.
Pricing
$310/0.1 mg | $1,330/5x0.1 mg | $465/0.1 mL (Biotin) | $465/0.1 mL (FITC) | $465/0.1 mL (AF350) | $465/0.1 mL (AF405) | $465/0.1 mL (AF488) | $465/0.1 mL (AF555) | $465/0.1 mL (AF568)
Affinity-purified fromrabbit antiserum by affinity-chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.
Pricing
$310/0.1 mg | $1,330/5x0.1 mg | $465/0.1 mL (Biotin) | $465/0.1 mL (FITC) | $465/0.1 mL (AF350) | $465/0.1 mL (AF405) | $465/0.1 mL (AF488) | $465/0.1 mL (AF555) | $465/0.1 mL (AF568)
$310/0.1 mg | $1,330/5x0.1 mg | $570/0.1 mL (Biotin) | $570/0.1 mL (FITC) | $570/0.1 mL (AF350) | $570/0.1 mL (AF405) | $570/0.1 mL (AF488) | $570/0.1 mL (AF555) | $570/0.1 mL (AF568)
$310/0.1 mg | $1,330/5x0.1 mg | $570/0.1 mL (Biotin) | $570/0.1 mL (FITC) | $570/0.1 mL (AF350) | $570/0.1 mL (AF405) | $570/0.1 mL (AF488) | $570/0.1 mL (AF555) | $570/0.1 mL (AF568)
$330/0.1 mL | $570/0.1 mL (Biotin) | $1,425/5x0.1 mL | $570/0.1 mL (FITC) | $570/0.1 mL (AF350) | $570/0.1 mL (AF405) | $570/0.1 mL (AF488) | $570/0.1 mL (AF555) | $570/0.1 mL (AF568)
$310/0.1 mg | $1,330/5x0.1 mg | $570/0.1 mL (Biotin) | $570/0.1 mL (FITC) | $570/0.1 mL (AF350) | $570/0.1 mL (AF405) | $570/0.1 mL (AF488) | $570/0.1 mL (AF555) | $570/0.1 mL (AF568)
$310/0.1 mg | $1,330/5x0.1 mg | $570/0.1 mL (Biotin) | $570/0.1 mL (FITC) | $570/0.1 mL (AF350) | $570/0.1 mL (AF405) | $570/0.1 mL (AF488) | $570/0.1 mL (AF555) | $570/0.1 mL (AF568)
$330/0.1 mL | $570/0.1 mL (Biotin) | $1,425/5x0.1 mL | $570/0.1 mL (FITC) | $570/0.1 mL (AF350) | $570/0.1 mL (AF405) | $570/0.1 mL (AF488) | $570/0.1 mL (AF555) | $570/0.1 mL (AF568)
$330/0.1 mL | $570/0.1 mL (Biotin) | $1,425/5x0.1 mL | $570/0.1 mL (FITC) | $570/0.1 mL (AF350) | $570/0.1 mL (AF405) | $570/0.1 mL (AF488) | $570/0.1 mL (AF555) | $570/0.1 mL (AF568)
$310/0.1 mg | $1,330/5x0.1 mg | $570/0.1 mL (Biotin) | $570/0.1 mL (FITC) | $570/0.1 mL (AF350) | $570/0.1 mL (AF405) | $570/0.1 mL (AF488) | $570/0.1 mL (AF555) | $570/0.1 mL (AF568)
$310/0.1 mg | $1,330/5x0.1 mg | $570/0.1 mL (Biotin) | $570/0.1 mL (FITC) | $570/0.1 mL (AF350) | $570/0.1 mL (AF405) | $570/0.1 mL (AF488) | $570/0.1 mL (AF555) | $570/0.1 mL (AF568)
$310/0.1 mg | $1,330/5x0.1 mg | $570/0.1 mL (Biotin) | $570/0.1 mL (FITC) | $570/0.1 mL (AF350) | $570/0.1 mL (AF405) | $570/0.1 mL (AF488) | $570/0.1 mL (AF555) | $570/0.1 mL (AF568)
Affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Pricing
$310/0.1 mg | $1,330/5x0.1 mg | $465/0.1 mL (Biotin) | $465/0.1 mL (FITC) | $465/0.1 mL (AF350) | $465/0.1 mL (AF405) | $465/0.1 mL (AF488) | $465/0.1 mL (AF555) | $465/0.1 mL (AF568)
$310/0.1 mg | $1,330/5x0.1 mg | $570/0.1 mL (Biotin) | $570/0.1 mL (FITC) | $570/0.1 mL (AF350) | $570/0.1 mL (AF405) | $570/0.1 mL (AF488) | $570/0.1 mL (AF555) | $570/0.1 mL (AF568)
Affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Pricing
$310/0.1 mg | $1,330/5x0.1 mg | $465/0.1 mL (Biotin) | $465/0.1 mL (FITC) | $465/0.1 mL (AF350) | $465/0.1 mL (AF405) | $465/0.1 mL (AF488) | $465/0.1 mL (AF555) | $465/0.1 mL (AF568)
$310/0.1 mg | $1,330/5x0.1 mg | $570/0.1 mL (Biotin) | $570/0.1 mL (FITC) | $570/0.1 mL (AF350) | $570/0.1 mL (AF405) | $570/0.1 mL (AF488) | $570/0.1 mL (AF555) | $570/0.1 mL (AF568)
Affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Pricing
$310/0.1 mg | $1,330/5x0.1 mg | $465/0.1 mL (Biotin) | $465/0.1 mL (FITC) | $465/0.1 mL (AF350) | $465/0.1 mL (AF405) | $465/0.1 mL (AF488) | $465/0.1 mL (AF555) | $465/0.1 mL (AF568)
$310/0.1 mg | $1,330/5x0.1 mg | $570/0.1 mL (Biotin) | $570/0.1 mL (FITC) | $570/0.1 mL (AF350) | $570/0.1 mL (AF405) | $570/0.1 mL (AF488) | $570/0.1 mL (AF555) | $570/0.1 mL (AF568)
Affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Pricing
$310/0.1 mg | $1,330/5x0.1 mg | $465/0.1 mL (Biotin) | $465/0.1 mL (FITC) | $465/0.1 mL (AF350) | $465/0.1 mL (AF405) | $465/0.1 mL (AF488) | $465/0.1 mL (AF555) | $465/0.1 mL (AF568)
Affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Pricing
$310/0.1 mg | $1,330/5x0.1 mg | $465/0.1 mL (Biotin) | $465/0.1 mL (FITC) | $465/0.1 mL (AF350) | $465/0.1 mL (AF405) | $465/0.1 mL (AF488) | $465/0.1 mL (AF555) | $465/0.1 mL (AF568)
Affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Pricing
$310/0.1 mg | $1,330/5x0.1 mg | $465/0.1 mL (Biotin) | $465/0.1 mL (FITC) | $465/0.1 mL (AF350) | $465/0.1 mL (AF405) | $465/0.1 mL (AF488) | $465/0.1 mL (AF555) | $465/0.1 mL (AF568)
$310/0.1 mg | $1,330/5x0.1 mg | $570/0.1 mL (Biotin) | $570/0.1 mL (FITC) | $570/0.1 mL (AF350) | $570/0.1 mL (AF405) | $570/0.1 mL (AF488) | $570/0.1 mL (AF555) | $570/0.1 mL (AF568)
Affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Pricing
$310/0.1 mg | $1,330/5x0.1 mg | $465/0.1 mL (Biotin) | $465/0.1 mL (FITC) | $465/0.1 mL (AF350) | $465/0.1 mL (AF405) | $465/0.1 mL (AF488) | $465/0.1 mL (AF555) | $465/0.1 mL (AF568)
$310/0.1 mg | $1,330/5x0.1 mg | $570/0.1 mL (Biotin) | $570/0.1 mL (FITC) | $570/0.1 mL (AF350) | $570/0.1 mL (AF405) | $570/0.1 mL (AF488) | $570/0.1 mL (AF555) | $570/0.1 mL (AF568)
$330/0.1 mL | $570/0.1 mL (Biotin) | $1,425/5x0.1 mL | $570/0.1 mL (FITC) | $570/0.1 mL (AF350) | $570/0.1 mL (AF405) | $570/0.1 mL (AF488) | $570/0.1 mL (AF555) | $570/0.1 mL (AF568)
$330/0.1 mL | $570/0.1 mL (Biotin) | $1,425/5x0.1 mL | $570/0.1 mL (FITC) | $570/0.1 mL (AF350) | $570/0.1 mL (AF405) | $570/0.1 mL (AF488) | $570/0.1 mL (AF555) | $570/0.1 mL (AF568)
$330/0.1 mL | $570/0.1 mL (Biotin) | $1,425/5x0.1 mL | $570/0.1 mL (FITC) | $570/0.1 mL (AF350) | $570/0.1 mL (AF405) | $570/0.1 mL (AF488) | $570/0.1 mL (AF555) | $570/0.1 mL (AF568)
$330/0.1 mL | $570/0.1 mL (Biotin) | $1,425/5x0.1 mL | $570/0.1 mL (FITC) | $570/0.1 mL (AF350) | $570/0.1 mL (AF405) | $570/0.1 mL (AF488) | $570/0.1 mL (AF555) | $570/0.1 mL (AF568)
$330/0.1 mL | $570/0.1 mL (Biotin) | $1,425/5x0.1 mL | $570/0.1 mL (FITC) | $570/0.1 mL (AF350) | $570/0.1 mL (AF405) | $570/0.1 mL (AF488) | $570/0.1 mL (AF555) | $570/0.1 mL (AF568)
Affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Pricing
$310/0.1 mg | $1,330/5x0.1 mg | $465/0.1 mL (Biotin) | $465/0.1 mL (FITC) | $465/0.1 mL (AF350) | $465/0.1 mL (AF405) | $465/0.1 mL (AF488) | $465/0.1 mL (AF555) | $465/0.1 mL (AF568)
Affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Pricing
$310/0.1 mg | $1,330/5x0.1 mg | $465/0.1 mL (Biotin) | $465/0.1 mL (FITC) | $465/0.1 mL (AF350) | $465/0.1 mL (AF405) | $465/0.1 mL (AF488) | $465/0.1 mL (AF555) | $465/0.1 mL (AF568)
Affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Pricing
$310/0.1 mg | $1,330/5x0.1 mg | $465/0.1 mL (Biotin) | $465/0.1 mL (FITC) | $465/0.1 mL (AF350) | $465/0.1 mL (AF405) | $465/0.1 mL (AF488) | $465/0.1 mL (AF555) | $465/0.1 mL (AF568)
$310/0.1 mg | $1,330/5x0.1 mg | $570/0.1 mL (Biotin) | $570/0.1 mL (FITC) | $570/0.1 mL (AF350) | $570/0.1 mL (AF405) | $570/0.1 mL (AF488) | $570/0.1 mL (AF555) | $570/0.1 mL (AF568)
$310/0.1 mg | $1,330/5x0.1 mg | $570/0.1 mL (Biotin) | $570/0.1 mL (FITC) | $570/0.1 mL (AF350) | $570/0.1 mL (AF405) | $570/0.1 mL (AF488) | $570/0.1 mL (AF555) | $570/0.1 mL (AF568)
$310/0.1 mg | $1,330/5x0.1 mg | $570/0.1 mL (Biotin) | $570/0.1 mL (FITC) | $570/0.1 mL (AF350) | $570/0.1 mL (AF405) | $570/0.1 mL (AF488) | $570/0.1 mL (AF555) | $570/0.1 mL (AF568)
$330/0.1 mL | $570/0.1 mL (Biotin) | $1,425/5x0.1 mL | $570/0.1 mL (FITC) | $570/0.1 mL (AF350) | $570/0.1 mL (AF405) | $570/0.1 mL (AF488) | $570/0.1 mL (AF555) | $570/0.1 mL (AF568)
$310/0.1 mg | $1,330/5x0.1 mg | $570/0.1 mL (Biotin) | $570/0.1 mL (FITC) | $570/0.1 mL (AF350) | $570/0.1 mL (AF405) | $570/0.1 mL (AF488) | $570/0.1 mL (AF555) | $570/0.1 mL (AF568)
Immunohistochemistry (IHC) (Immunohistochemistry analysis of paraffin-embedded human brain tissue using CDH9 antibody. Western blot analysis of extracts from COLO cells, using CDH9 antibody.)
Immunofluorescence (IF) (Peptide-+ Immunofluorescence analysis of HeLa cells, using CDH9 antibody.)
Western Blot (WB) (Figure 1. Western blot analysis using AMACR mouse mAb against Jurkat (1) and LNCaP (2) cell lysate.)
Immunohistochemistry (IHC) (Figure 2. Immunohistochemical analysis of paraffin-embedded human normal prostate tissues (left) and prostate adenocarcinoma tissues (right), showing cytoplasmic localization using AMACR mouse mAb with DAB staining.)
Immunohistochemistry (IHC) (Figure 3. Immunohistochemical analysis of paraffin-embedded human brain cerebellum using AMACR mouse mAb.)
Immunohistochemistry (IHC) (Immunohistochemistry analysis of paraffin-embedded human brain tissue using CAMK5 antibody. Western blot analysis of extracts from HepG2 cells and HUVEC cells, using CAMK5 antibody.)
Immunofluorescence (IF) (Peptide-+ Immunofluorescence analysis of HeLa cells, using CAMK5 antibody.)
Western Blot (WB) (Figure 1: Western blot analysis using THAP11 mouse mAb against Hela (1) and NTERA-2 (2) cell lysate.)
Immunohistochemistry (IHC) (Figure 2: Immunohistochemical analysis of paraffin-embedded colon cancer tissues (left) and ovary cancer tissues (right) using THAP11 mouse mAb with DAB staining.)
Immunofluorescence (IF) (Figure 3: Immunofluorescence analysis of NTERA-2 cells using THAP11 mouse mAb (green). Red: Actin filaments have been labeled with Alexa Fluor-555 phalloidin.)
Western Blot (WB) (Figure 1: Western blot analysis using STAT3 mouse mAb against Hela (1), NIH/3T3 (2), Jurkat (3), PC-12 (4) and COS7 (5) cell lysate.)
Immunohistochemistry (IHC) (Figure 2: Immunohistochemical analysis of paraffin-embedded mammary cancer tissues (left) and lung cancer tissues (right) using STAT3 mouse mAb with DAB staining.)
Immunofluorescence (IF) (Figure 3: Immunofluorescence analysis of Hela cells using STAT3 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor-555 phalloidin.)
Testing Data (Figure 1. Western blot analysis using S100A10/P11 mouse mAb against MCF-7 (1), HepG2 (2) and Hela (3).)
Testing Data #2 (Figure 2. Immunohistochemical analysis of paraffin-embedded human nerve and ganglion cells using S100A10/P11 mouse mAb.)
Testing Data #3 (Figure 3. Confocal immunofluorescence analysis of Hela (left) and L-02 (right) cells using S100A10/P11 mouse mAb(green). Red. Actin filaments have been labeled with DY-554 phalloidin. Blue. DRAQ5 fluorescent DNA dye.)
Western Blot (Western blot analysis using HK1 mouse mAb against Jurkat (1), Hela (2), HepG2 (3) and NIH/3T3 (4) cell lysate.)
Immunofluorescence (Immunofluorescence analysis of NIH/3T3 cells using HK1 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor-555 phalloidin.)
Immunohistochemistry (Immunohistochemical analysis of paraffin-embedded kidney tissues using HK1 mouse mAb with DAB staining.)
Western Blot (WB) (Western blot analysis of CTSK (arrow) using rabbit polyclonal CTSK Antibody (Center E112). 293 cell lysates (2 ug/lane) either nontransfected (Lane 1) or transiently transfected (Lane 2) with the CTSK gene.)
Immunohistochemistry (IHC) (CTSK Antibody (Center E112) immunohistochemistry analysis in formalin fixed and paraffin embedded human skeletal muscle followed by peroxidase conjugation of the secondary antibody and DAB staining.This data demonstrates the use of CTSK Antibody (Center E112) for immunohistochemistry. Clinical relevance has not been evaluated.)
Flow Cytometry (FC/FACS) (CTSK Antibody (Center E112) flow cytometric analysis of 293 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.)
Western Blot (WB) (Western blot analysis of AKT2 Antibody in NCI-H460 cell line lysates (35ug/lane). AKT2 (arrow) was detected using the purified Pab.)
Western Blot (WB) (Western blot analysis of AKT2 Antibody in mouse brain tissue lysates (35ug/lane). AKT2 (arrow) was detected using the purified Pab.)
Flow Cytometry (FC/FACS) (AKT2 Antibody flow cytometric analysis of NCI-H460 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.)
Immunofluorescence (IF) (Confocal immunofluorescent analysis of AKT2 Antibody with 293 cell followed by Alexa Fluor 488-conjugated goat anti-rabbit lgG (green).Actin filaments have been labeled with Alexa Fluor 555 phalloidin (red).DAPI was used to stain the cell nuclear (blue).)
Immunohistochemistry (IHC) (Immunohistochemistry analysis of paraffin-embedded human testis tissue using HDAC6 (Phospho-Ser22) antibody. Western blot analysis of extracts from NIH/3T3 cells, treated with Anisomycin (25mug/ml, 30mins), using HDAC6 (Phospho-Ser22) antibody.)
Immunofluorescence (IF) (P-peptide-+ Immunofluorescence analysis of HepG2 cells, using HDAC6 (Phospho-Ser22) antibody.)
Immunohistochemistry (IHC) (Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary antibody, which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated. BC = breast carcinoma; HC = hepatocarcinoma.)
Western Blot (WB) (APG9L1 Antibody (W267) western blot analysis in A2058 cell line lysates (35ug/lane).This demonstrates the APG9L1 antibody detected the APG9L1 protein (arrow).)
Western Blot (WB) (APG9L1 Antibody (W267) western blot analysis in mouse heart tissue lysates (35ug/lane).This demonstrates the APG9L1 antibody detected the APG9L1 protein (arrow).)
Immunohistochemistry (IHC) (Immunohistochemistry analysis of paraffin-embedded human colon carcinoma tissue using p47 phox (Phospho-Ser359) antibody. Western blot analysis of extracts from HeLa cells treated with nocodazole (1ug/ml, 18hours) and HeLa cells treated with TSA (400nM, 24hours), using p47 phox (Phospho-Ser359) antibody.)
Immunofluorescence (IF) (P-peptide-+ Immunofluorescence analysis of HeLa cells, using p47 phox (Phospho-Ser359) antibody.)
Western Blot (WB) (Western blot analysis of PRDX3 Antibody (N-term) in NCI-H460,MDA-MB231,HepG2 cell line lysates (35ug/lane). PRDX3 (arrow) was detected using the purified Pab.(2ug/ml))
Immunohistochemistry (IHC) (Formalin-fixed and paraffin-embedded human lung carcinoma reacted with PRDX3 Antibody (N-term), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.)
Flow Cytometry (FC/FACS) (Flow cytometric analysis of MDA-MB468 cells using PRDX3 Antibody (N-term)(bottom histogram) compared to a negative control cell (top histogram)FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.)
Western Blot (WB) (Western blot analysis of PRDX3 (arrow) using rabbit polyclonal PRDX3 Antibody (N-term). 293 cell lysates (2 ug/lane) either nontransfected (Lane 1) or transiently transfected (Lane 2) with the PRDX3 gene.)
Western Blot (WB) (Western blot analysis of extracts of mouse serumcell lines, using TTR antibody. Immunohistochemistry of paraffin-embeddedhuman renal cancer tissue using TTR antibody.)
Testing Data
Western Blot (WB) (Figure 1. Western blot analysis using BMP4 mouse mAb against BMP4-hIgGFc transfected HEK293 cell lysate.)
Western Blot (WB) (Figure 1: Western blot analysis using EIF2AK3 mAb against HEK293 (1) and EIF2AK3-hIgGFc transfected HEK293 (2) cell lysate.)
Western Blot (WB) (Figure 1. Western blot analysis using LIN28 mouse mAb against NTERA-2 cell lysate (1).)
Immunofluorescence (IF) (Figure 2. Confocal immunofluorescence analysis of methanol fixed Hela cells were transfected with pMX construct of human LIN28, cells were analyzed ~62 hours after transfection.)
Immunofluorescence (IF) (Figure 3. Confocal immunofluorescence analysis of NTERA-2 cells using LIN28 mouse mAb (green). Blue. DRAQ5 fluorescent DNA dye.)
Western Blot (WB) (Figure 1: Western blot analysis using GPI mouse mAb against HepG2 (1), SMMC-7721 (2) cell lysate and rat liver tissues lysate (3).)
Western Blot (WB) (Figure 2: Western blot analysis using GPI mouse mAb against HEK293T cells transfected with the pCMV6-ENTRY control (1) and pCMV6-ENTRY GPI cDNA (2).)
Immunohistochemistry (IHC) (Figure 3: Immunohistochemical analysis of paraffin-embedded human Kidney tissues using GPI mouse mAb.)
Immunohistochemistry (IHC) (Immunohistochemistry analysis of paraffin-embedded human prostate carcinoma tissue using RPL36 antibody. Western blot analysis of extracts from COLO cells, using RPL36 antibody.)
Immunofluorescence (IF) (Peptide-+ Immunofluorescence analysis of A549 cells, using RPL36 antibody.)
Immunohistochemistry (IHC) (Immunohistochemistry analysis of paraffin-embedded human skeletal muscle tissue using Collagen XX alpha1 antibody. Western blot analysis of extracts from HUVEC cells, using Collagen XX alpha1 antibody.)
Immunofluorescence (IF) (Peptide-+ Immunofluorescence analysis of NIH/3T3 cells, using Collagen XX alpha1antibody.)
Western Blot (WB) (Figure 1. Western blot analysis using NCOA3 mouse mAb against truncated Trx-NCOA3 recombinant protein (1) and truncated NCOA3 (aa1-200)-hIgGFc transfected CHOK1 cell lysate (2).)
Immunohistochemistry (IHC) (Immunohistochemistry analysis of paraffin-embedded human brain tissue using GLCTK antibody. Western blot analysis of extracts from 3T3 cells, using GLCTK antibody.)
Immunofluorescence (IF) (Peptide-+ Immunofluorescence analysis of A549 cells, using GLCTK antibody.)
Western Blot (WB) (Figure 1: Western blot analysis using CRTC2 mouse mAb against Hela (1) and HEK293 (2) cell lysate.)
Immunohistochemistry (IHC) (Figure 2: Immunohistochemical analysis of paraffin-embedded ovary tumour tissues (left) and lung cancer (right) using CRTC2 mouse mAb with DAB staining.)
Immunofluorescence (IF) (Figure 3: Immunofluorescence analysis of Hela cells using CRTC2 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor-555 phalloidin.)
Immunohistochemistry (IHC) (Peptide-+ Immunohistochemical analysis of paraffin-embedded human brain tissue using Tyrosine Hydroxylase (Ab-40) antibody.)
Western Blot (WB) (Western blot analysis of extracts from 3T3 cells treated with Forskolin (40nM, 30min), using Tyrosine Hydroxylase (Ab-40) antibody.)
Immunofluorescence (IF) (Peptide-+ Immunofluorescence analysis of HuvEc cells, using Tyrosine Hydroxylase (Ab-40) antibody.)
Immunohistochemistry (IHC) (Immunohistochemistry analysis of paraffin-embedded human brain tissue using NMDAR1 (Ab-890) antibody. Western blot analysis of extracts from Jurkat cells, using NMDAR1 (Ab-890) antibody.)
Immunofluorescence (IF) (Peptide-+ Immunofluorescence analysis of NIH/3T3 cells, using NMDAR1 (Ab-890) antibody.)
Immunohistochemistry (IHC) (Immunohistochemistry analysis of paraffin-embedded human breast carcinoma tissue using CBL (Ab-700) antibody. Western blot analysis of extracts from 293 cells, using CBL (Ab-700) antibody.)
Immunofluorescence (IF) (Peptide-+ Immunofluorescence analysis of COS7 cells, using CBL (Ab-700) antibody.)
Western Blot (Western blot analysis using HSP90AB1 mouse mAb against Jurkat (1), A431 (2), Hela (3), A549 (4), HEK293 (5), K562 (6), NIH/3T3 (7), PC-12 (8) and Cos7 (9) cell lysate.)
Immunohistochemistry (Immunohistochemical analysis of paraffin-embedded prostate cancer tissues (left) and lung cancer tissues (right) using HSP90AB1 mouse mAb with DAB staining.)
Immunohistochemistry (IHC) (Immunohistochemistry analysis of paraffin-embedded human breast carcinoma tissue using FAK (Ab-397) antibody. Western blot analysis of extracts from 293 cells, using FAK (Ab-397) antibody.)
Immunofluorescence (IF) (Peptide-+ Immunofluorescence analysis of HeLa cells, using FAK (Ab-397) antibody.)
Western Blot (WB) (Figure 1. Western blot analysis using BCL10 mouse mAb against NIH/3T3 (1), Hela (2), MCF-7 (3) and Jurka (4) cell lysate)
Immunohistochemistry (IHC) (Figure 2. Immunohistochemical analysis ofparaffin-embedded human breast carcinoma (A) and liver carcinoma (B), showing cytoplasmic localization using BCL10mouse mAb with DAB staining.)
Immunofluorescence (IF) (Figure 3.Confocal immunofluorescence analysis of Hela (left) and NTERA-2 (right) cells using NPM mouse mAb (green). Red: Actin filaments have been labeled with DY-554 phalloidin.)
Immunohistochemistry (IHC) (Immunohistochemistry analysis of paraffin-embedded human ovary tissue using FGF22 antibody. Western blot analysis of extracts from Jurkat cells and HT-29 cells, using FGF22 antibody.)
Immunofluorescence (IF) (Peptide-+ Immunofluorescence analysis of MCF-7 cells, using FGF22 antibody.)
Immunohistochemistry (IHC) (Immunohistochemistry analysis of paraffin-embedded human skeletal muscle tissue using MRPS18C antibody. Western blot analysis of extracts from K562 cells, using MRPS18C antibody.)
Immunofluorescence (IF) (Peptide-+ Immunofluorescence analysis of MCF-7 cells, using MRPS18C antibody.)
Immunohistochemistry (IHC) (Immunohistochemistry analysis of paraffin-embedded human breast carcinoma tissue using Caldesmon (Ab-789) antibody. Western blot analysis of extracts from HeLa cells, treated with EGF (200ng/ml, 30mins), using Caldesmon (Ab-789) antibody.)
Immunofluorescence (IF) (Peptide-+ Immunofluorescence analysis of HeLa cells, using Caldesmon (Ab-789) antibody.)
Western Blot (WB) (Western blot analysis of TIMP3 Antibody (Center) in HepG2 cell line lysates (35ug/lane). TIMP3 (arrow) was detected using the purified Pab.)
Western Blot (WB) (Western blot analysis of TIMP3 Antibody (Center) Pab pre-incubated without(lane 1) and with(lane 2) blocking peptide in mouse NIH-3T3 cell line lysate. TIMP3 Antibody (Center) (arrow) was detected using the purified Pab.)
Immunohistochemistry (IHC) (Formalin-fixed and paraffin-embedded human breast carcinoma reacted with TIMP3 Antibody (Center), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.)
Flow Cytometry (FC/FACS) (TIMP3 Antibody (Center) flow cytometric analysis of MCF-7 cells (bottom histogram) compared to a negative control cell (top histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.)
Western Blot (WB) (Figure 1: Western blot analysis using NME1 mAb against NME1-hIgGFc transfected HEK293 cell lysate.)
Immunohistochemistry (IHC) (Figure 2: Immunohistochemical analysis of paraffin-embedded human Placenta tissues using anti-NME1 mouse mAb)
Immunofluorescence (IF) (Figure 3: Immunofluorescence analysis of Hela cells using NME1 mouse mAb (green). Red: Actin filaments have been labeled with Alexa Fluor-555 phalloidin. Blue: DRAQ5 fluorescent DNA dye.)
Testing Data (Figure 1. Western blot analysis using IL2 mouse mAb against full-length IL2 recombinant protein with Trx tag (1) and full-length IL2-hIgGFc transfected HEK293 cell lysate(2).)
Western Blot (WB) (Figure 1: Western blot analysis using GFI1 mAb against HEK293 (1) and GFI1-hIgGFc transfected HEK293 (2) cell lysate.)
Testing Data (Figure 1. Western blot analysis using CK mouse mAb against truncated CK5 recombinant protein.)
Testing Data #2 (Figure 2. Immunohistochemical analysis of paraffin-embedded human lung squamous cell carcinoma (A),normal hepatocyte (B), colon adenocacinoma?, normal stomach tissue (D), showing cytoplasmic and membrane localization using CK mouse mAb with DAB staining.)
Testing Data #3 (Figure 3. Immunohistochemical analysis of paraffin-embedded human Skin tissues using CK mouse mAb)
Request more Information
Please complete the form below and a representative will contact you as soon as possible.
Request a Manual
Please complete the form below and a representative will contact you as soon as possible.
Request a Quote
Please complete the form below and a representative will contact you as soon as possible.